NCT00489723

Brief Summary

The purpose of this study is to determine if there is a role of prophylactic therapy with tamsulosin prior extracorporeal shock wave lithotripsy to avoid development of steinstrasse. 150 persons that will go to Extracorporeal shock wave lithotripsy will randomize to 2 groups. Group 1 -of 75 persons will recieve tamsulosin 0.4 mg x 1/d 2 days before the lithotripsy . Group 2 - of 75 persons will not recieve tamsulosin. 48 hour after the ESWL all 2 group will take abdominal radiograph to evaluate the presence of steinstrasse.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 21, 2007

Completed
Last Updated

June 21, 2007

Status Verified

June 1, 2007

First QC Date

June 19, 2007

Last Update Submit

June 20, 2007

Conditions

Kidney Stones

Keywords

size of stone 1-2 cmPt. with no use of alfa bloker prior ESWLPt. without internal stent

Interventions

tamsulosin 0.4mgDRUG

Eligibility Criteria

Age15 Years - 85 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • size of stone 1-2 cm

You may not qualify if:

  • ureteral stricture Presence of internal stent prior use of alfa bloker prior ESWL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haemek medical center

Afula, 18100, Israel

RECRUITING

MeSH Terms

Conditions

Kidney Calculi

Interventions

Tamsulosin

Condition Hierarchy (Ancestors)

NephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisUrinary CalculiMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BenzenesulfonamidesSulfonamidesAmidesOrganic ChemicalsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsSulfonesSulfur Compounds

Study Officials

  • doron perez

    Urology department: Haemek Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

DORON PEREZ, M.D.

CONTACT

+972-4-6495115perez_do@clalit.org.il

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 19, 2007

First Posted

June 21, 2007

Study Start

May 1, 2007

Last Updated

June 21, 2007

Record last verified: 2007-06

Locations

IL(1)